Dose rationalisation of pembrolizumab and nivolumab using pharmacokinetic modelling and simulation and cost analysis
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 64346561
- Type
- D - Journal article
- DOI
-
10.1002/cpt.875
- Title of journal
- Clinical Pharmacology & Therapeutics
- Article number
- -
- First page
- 582
- Volume
- 103
- Issue
- 4
- ISSN
- 0009-9236
- Open access status
- Compliant
- Month of publication
- September
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
5
- Research group(s)
-
A - Pharmacy and Optometry
- Citation count
- 27
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
